Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

NCT01772004

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Cortex Diseases, +62 more
Locations
  • Cancer Treatment Centers of America - Western Regional Medical Center Goodyear, Arizona, United States
  • Scottsdale Healthcare Corporation Scottsdale, Arizona, United States
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 74 locations
View Trial Details
Completed

REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

NCT03916458

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital San Juan de Dios Manresa, Barcelona, Spain
  • Hospital Parc Taulí de Sabadell Sabadell, Barcelona, Spain
  • Hospital Universitario Mutua Terrassa Terrassa, Barcelona, Spain
View all 31 locations
View Trial Details
Completed

A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

NCT00730639

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

NCT01472081

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • City Of Hope Duarte, California, United States
  • Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 14 locations
View Trial Details
Completed

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

NCT00550277

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Baton Rouge General Medical Center Baton Rouge, Louisiana, United States
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
View Trial Details
Completed

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

NCT03319459

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +63 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • The Ohio State University James Cancer Hospital Columbus, Ohio, United States
  • Baylor Scott & White Research Institute Dallas, Texas, United States
View Trial Details

Related conditions